Licensed Antibodies definition

Licensed Antibodies means those Program Antibodies that are selected by Surface pursuant to Section 3.3(a), and any Program-Benefited Antibody generated from such Program Antibodies.

Licensed Antibodies means the antibodies known as of the Effective Date as BA3362 and [***], each as more specifically described in Schedule 1(a);

Licensed Antibodies means (a) all CSF1R Antibodies Controlled by Five Prime as of the Effective Date, including FPA008 and the Antibodies set forth on Exhibit B, (b) all CSF1R Antibodies Controlled or otherwise researched or developed by BMS during the Restricted Period, and (c) all modifications, derivatives, fragments or variants of any CSF1R Antibody set forth in part (a) or (b) of this definition.

Examples of Licensed Antibodies in a sentence

• During the Term, in the event that Context reasonably believes additional BioAtla Know-How is necessary for the continued Exploitation of the Licensed Antibodies or Program Products, Context may reasonably request a copy of such additional BioAtla Know-How from BioAtla.

• BioAtla shall provide to Context copies of all pre-clinical data and results from any and all completed pre-clinical activity for the Program Products or Licensed Antibodies, in electronic form or other mutually agreeable alternate form within [***] days following the Effective Date.

• Subject to the terms and conditions hereunder, BioAtla hereby grants Context an exclusive license (exclusive even as to BioAtla and its Affiliates), sublicensable (with right of sublicense through multiple tiers), under the BioAtla Intellectual Property solely for the Exploitation of the Licensed Antibodies and Program Products in the Field in the Territory (collectively, the “License”).

• Notwithstanding anything to the contrary in the ERA, Himalaya and BioAtla acknowledge and agree that the research and development work performed by BioAtla to date with respect to the Licensed Antibodies (as defined in the Context License Agreement) is not deemed to have been performed pursuant to the ERA.

• Himalaya hereby acknowledges that as between the Parties, the identity and characteristics of the Licensed Antibodies and Program Products (each as defined in the Context License Agreement), the terms set forth on Exhibit A, and any information disclosed by BioAtla to Himalaya regarding the Licensed Antibodies and Program Products shall be deemed to be the Confidential Information of BioAtla.

More Definitions of Licensed Antibodies

Licensed Antibodies means (a) the VEGFR2 and PDL-1 monoclonal antibodies generated by Kadmon, and (b) any and all human monoclonal antibodies developed by Jinghua using the Technology.

Licensed Antibodies means (i) Antibody [***] and all other Licensed Antibodies (as defined in the Option Agreement), including the antibodies listed on Exhibit A hereto, (ii) all monoclonal antibodies identified or generated by Inhibrx and/or its Affiliates during the Term directed against the Target, and (iii) any analog, fragment, variant, modification or derivative of any of the foregoing.

Licensed Antibodies means the Lead Antibody and the Back-up Antibodies.

Licensed Antibodies means the antibodies set forth in Exhibit A hereto, and any subsequent monoclonal antibodies owned, licensed or developed by M-Tech or its Affiliates that are directed towards the same antigens as the antibodies listed in Exhibit A. Expressly excluded from the Licensed Antibodies are any subclone cell lines isolated from the [***] cell line other than those that primarily produce human monoclonal antibodies to [***], whether alone or in combination with other antigens.

Licensed Antibodies means those antibodies set forth on Schedule 2.2 hereto. ***** Confidential material redacted and filed separately with the Commission.

Licensed Antibodies. Phase III (3 November 1997 - 6 March 1998) - Ascites production of 10 mAbs - PerImmune provides 4mg of purified Lp(a) to Sigma Phase IV (9 March 1998 - 27 November 1998) - PerImmune transfers selected monoclonal bybridoma cell lines to Sigma - Sigma establishes conditions and GMP processes for production of mAbs in hollow fiber bioreactors Phase V (30 March 1998 - 11 September 1998) - Development of Calibrators and Controls Phase VI (14 September 1998 - 9 October 1998) - Sigma demonstrates homogenous immunoturbidometric Lp(a) assay equivalent to Apo-Tek Lp(a) product On this 30th day of June 1997, before me, a Notary Public, personally appeared Michxxx X. Xxxxx, Xx. xx me known to be the persons described in and who executed the foregoing assignment and acknowledged that he/she executed same as his/her free act and deed. IN TESTIMONY WHEREOF, I have hereunto set my hand and seal the date and year last above written. /s/ EVELXX XXXXXXX XXXXXXXX ----------------------------- Notary Public My commission expires: May 15, 1999 XXXXX XX XXXXXXXX ) ) COUNTY OF ST. LOUIS ) On this 26 day of June 1997, before me, a Notary Public, personally appeared Michxxx X. Xxxxxxx xx me known to be the persons described in and who executed the foregoing assignment and acknowledged that he/she executed same as his/her free act and deed. IN TESTIMONY WHEREOF, I have hereunto set my hand and seal the date and year last above written. /s/ NANCX X. XXXXXX ----------------------------- Notary Public My commission expires: Aug. 21, 2000

Licensed Antibodies means (a) the human monoclonal antibodies identified in Exhibit A attached hereto, and (b) all antibodies directed to, raised against or that bind to M2e and/or HA discovered by or for Theraclone (or its Affiliate) or the Patents Covering which or Know-How pertaining to which are owned or Controlled by any of the foregoing, in each case at any time (including prior to or as of the Effective Date or at any time during the term of this Agreement). To avoid doubt, the term “antibody” as used in this definition and this Agreement includes both full-length antibodies, fragments thereof (that contain the complementarity-determining region (or “CDR”), and chemically modified versions thereof (including pegylated versions and regardless of whether containing amino acid substitutions)), all of the foregoing whether naturally occurring, artificially produced, raised in an artificial system, or created through modification of an antibody produced in any of the foregoing ways or otherwise.